INSM1 and pancreatic insulinoma: In a hybrid AB6F1 genetic background, low expression levels of a beta cell transcription factor, Insm1, favors development of nonfunctioning tumors, whereas in a C57Bl/6 genetic background, higher expression of Insm1 favors development of insulinomas.